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Abstract
Golden-Syrian hamsters have been used as an animal model to assess diet-induced atherosclerosis since the early
1980s. Advantages appeared to include a low rate of endogenous cholesterol synthesis, receptor-mediated uptake
of LDL cholesterol, cholesteryl ester transfer protein activity, hepatic apoB-100 and intestinal apoB-48 secretion, and
uptake of the majority of LDL cholesterol via the LDL receptor pathway. Early work suggested hamsters fed high
cholesterol and saturated fat diets responded similarly to humans in terms of lipoprotein metabolism and aortic
lesion morphology. Recent work has not consistently replicated these findings. Reviewed was the literature related
to controlled hamster feeding studies that assessed the effect of strain, background diet (non-purified, semi-
purified) and dietary perturbation (cholesterol and/or fat) on plasma lipoprotein profiles and atherosclerotic lesion
formation. F1B hamsters fed a non-purified cholesterol/fat-supplemented diet had more atherogenic lipoprotein
profiles (nHDL-C > HDL-C) than other hamster strains or hamsters fed cholesterol/fat-supplemented semi-purified
diets. However, fat type; saturated (SFA), monounsaturated or n-6 polyunsaturated (PUFA) had less of an effect on
plasma lipoprotein concentrations. Cholesterol- and fish oil-supplemented semi-purified diets yielded highly vari-
able results when compared to SFA or n-6 PUFA, which were antithetical to responses observed in humans. Diet-
ary cholesterol and fat resulted in inconsistent effects on aortic lipid accumulation. No hamster strain was reported
to consistently develop lesions regardless of background diet, dietary cholesterol or dietary fat type amount. In
conclusion, at this time the Golden-Syrian hamster does not appear to be a useful model to determine the
mechanism(s) of diet-induced development of atherosclerotic lesions.
Introduction
Cardiovascular disease (CVD) is the leading cause of
mortality in developed countries and is a growing health
challenge in developing countries [1,2]. The majority of
CVD is attributed to atherosclerosis, characterized by
endothelial dysfunction, chronic inflammation, dyslipide-
mia, and accumulation of lipid in arterial walls [1,3-10].
Data from both observational and interventional studies
indicate that dietary modification can alter atherosclero-
tic lesion progression [5,11,12]. Although the diet/CVD
relationship was first identified at the turn of the 20th
century [13], salient issues related to dietary fat type are
still in question [14-16].
Randomized controlled human intervention trials in
the field of diet and CVD are rare, in part due to the
complexity and cost of executing the studies, limited
number of validated surrogate biomarkers to track dis-
ease progression, and inaccessibility of pivotal tissues/
organs necessary to determine underlying mechanisms.
The availability of an animal model addresses the later
issue by allowing the assessment of diet and athero-
sclerosis development in multiple tissue systems simul-
taneously. This in turn facilitates a more complete
understanding of the complex relationship between diet
and CVD risk. In general, unmodified rats and mice are
not suitable animal models to study diet-induced
changes in plasma lipid and lipoprotein concentrations
and atherosclerotic lesion development because they do
not develop aortic lesions or an atherogenic lipoprotein
profile [non-high-density lipoprotein cholesterol (nHDL-
C) > high-density lipoprotein cholesterol (HDL-C)] simi-
lar to that observed in humans. Transgenic, knock-out,
and knock-down mouse models have been used success-
fully to study discrete components of the system
[17-21], but it is difficult to use these models to assess
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multi-component etiologies. Such questions are best
investigated using unmodified animal models.
Since the 1980s hamsters have been used as an animal
model to assess diet-induced atherosclerosis [22]. Rela-
tive to other unmodified rodent models, the hamster
was thought to be preferable due to its apparent low
rate of endogenous cholesterol synthesis, receptor-
mediated uptake of low density lipoprotein cholesterol,
presence of cholesteryl ester transfer protein (CETP)
activity [23-28], secretion of apolipoprotein (apo) B-100
from the liver and apo B-48 from the small intestine
[29], and uptake of the majority of LDL-C via the LDL
receptor pathway [22]. The morphology of aortic foam
cells and lesions in hamsters fed atherogenic diets was
reported to be similar to human lesions [22,30,31].
More recent work has not consistently replicated the
plasma lipoprotein response or aortic lesion morphology
in hamsters that was previously shown to be similar to
humans [31-43]. Our aim was to review the literature
regarding diet interventions in Golden-Syrian hamsters,
and plasma lipid and lipoprotein response and aortic
lesion formation.
Methods
Literature Search Strategy and Data Extraction
A literature search was conducted through January,
2010 in PubMed. The following search terms were used:
dietary cholesterol, dietary fat, and fatty acids. These
terms were crossed with hamster. Then the terms ather-
osclerosis and plasma lipoprotein were searched inde-
pendently and then crossed with hamster. Finally, the
results from the two searches were crossed. The search
was limited to English language publications. To ensure
completeness this method was supplemented by review-
ing citations in recent publications. Extracted data
included intervention period, male hamster strain, male
hamster age, background diet, and diet composition. For
the later point emphasis was placed on dietary choles-
terol amount, and dietary fat type and amount.
Results
Outcome Measures
Plasma lipid and lipoproteins
Studies that reported plasma cholesterol (total choles-
terol, HDL-C and nHDL-C) and/or plasma triglyceride
(TG) concentrations were included in the data summa-
ries. All plasma lipids were measured after hamsters
were food deprived.
Aortic lesion development
In general, two approaches have been used to measure
aortic lesions. The first method was oil red-O lipid
staining. These data were expressed using multiple sys-
tems; μm2 fatty streak/mm2 aorta [31,35,36,44-46], per-
cent total aortic lesion area [47,48], percent aortic arch
fatty streak area [49-51], percent foam cell area [52] or
aortic cross-sections as percent total “internal elastic


























TG Lesion Lesion Measure
[38] F1B 8 5 101 0.05 150 650 ↑ Aorta stained (μ2)
[31] F1B 8 8 102 0.05 58 58 1.0 87 88 234 2.7 216 ↑ Foam cells/mm2
aorta
[55] F1B 8 12 103 0.1 48 35 0.7 110 67 444 6.6 545 ↔ CE (ug)/aorta (mg
wet weight)
[55] CR 8 12 103 0.1 68 67 1.0 129 86 210 2.4 195 ↑ CE (ug)/aorta (mg
wet weight)
[49] CR 10 24 53 2 50 47 0.9 186 247 581 2.4 1912 ↑ Fatty streak area
(%)
[47] CR 8 6 102 0.1 71 25 0.4 219 108 112 1.0 341 ↔ Aorta with lesion
(% )
[47] CR 8 6 103 0.1 71 25 0.4 219 108 174 1.6 301 ↔ Aorta with lesion
(% )
[58] UNK 3-4 28 53 1 120 169 ↔ EC (ug)/aorta
(10mg dry
weight)
[50] UNK 5 40 102 0.3 87 64 0.7 102 153 224 1.5 295 ↑ Fatty streak area
(%)
SFA: saturated fatty acid; CH: cholesterol; HDL-C: high-density lipoprotein cholesterol; nHDL-C: non-HDL-C; TG: triglycerides; CR: Charles River; UNK: unknown
hamster strain; EC: esterified cholesterol. SFA source: 1Hydrogenated coconut oil, 2Coconut oil and 3Butter
Dillard et al. Nutrition & Metabolism 2010, 7:89
http://www.nutritionandmetabolism.com/content/7/1/89
Page 2 of 12
lamina” [30]. The use of multiple reporting systems
made cross comparisons among studies challenging. The
second method was determining aortic cholesteryl ester
(CE) content. The data tended to be either expressed as
either CE/mg aortic wet weight [37,39,53-57] or dry
weight [58]. Oil red-O staining provided a measure of
lesion surface area, but no data on the nature and inva-
siveness of the lesion. CE content provided an assess-
ment of total aortic cholesterol accumulation, but did
not provide an indication of the lesion type.
Covariates
Intervention period, hamster strain and sex, background
diet and diet composition, including amount of choles-
terol and type and amount of fat, were found to affect
outcome measures.
Intervention Periods
Intervention periods ranged from 3 weeks [59,60] to 12
months [22,61]. The most common intervention
periods ranged from 10 and 12 weeks [33-35,37,42,
43,46,48,51,53-56,62-66]. Outcome measures for the
shorter term studies (< 6 weeks) were primarily plasma
lipoprotein profiles and for the mid- to long-term stu-
dies (6-12 weeks) was aortic lesion formation.
Hamster Strain
Four Golden-Syrian hamster strains have been predomi-
nantly used to study diet-induced atherosclerosis. These
strains can be characterized as being derived from
inbred or outbred hamsters. In common usage, the one
inbred strain was the F1B hamster from Biobreeders
(Watertown, MA). The three outbred strains were
Charles River (CR) (Wilmington, MA), Sasco (Omaha,
NE) and Harlan (Indianapolis, IN).
Hamster Sex
The vast majority of studies used male hamsters only
(115 out of 120). Seven studies included female ham-
sters [38,43,67-71]. Of those, three studies reported on
fetal cholesterol metabolism only [69-71], two studies
compared plasma lipoprotein concentrations or athero-
sclerotic lesion development between female ovariecto-
mized and sham-operated hamsters [67,68], and two
studies compared plasma lipoprotein concentrations and
atherosclerotic lesion development between male and
female hamsters [38,43]. Due to the limited amount of
data and lack of comparable data, outcome measures for
female hamsters were not included.
Background Diet
Two distinct types of background diets have been used
for hamster studies: semi-purified and non-refined.
Semi-purified diets were composed of refined ingredi-
ents such as casein and sucrose, whereas non-purified
diets were composed of unmodified ingredients such as
grains and grain products. A standard vitamin and
mineral mix was added to both [72]. Semi-purified diets
were generally favored because they provide more uni-
formity and reproducibility.
Diet Composition
Dietary Cholesterol Studies designed to asses diet-
induced changes in plasma lipids or atherosclerosis, for
the most part, include supplemental cholesterol. The
levels used in most hamster studies exceed what was
considered high intake in humans. The amount of cho-
lesterol was of concern because large amounts (≥1% w/
w) were hepatotoxic; impairing normal lipoprotein
metabolism [30,55,73]. Hepatotoxicity has been charac-
terized by visual inspection of the liver or measuring
hepatic cholesterol content, hepatic lipoprotein metabo-
lism and apolipoprotein synthesis [23,25,55]. The
amount of supplemental dietary cholesterol identified
ranged from 0 to 3% (w/w) [22,30,64,74]. The majority
of studies have used between 0.05 to 0.2% cholesterol
(w/w) [30-36,39,40,42,43,46-48,51-56,59,62,63,66,75-94].
Dietary Fat Studies feeding hamsters diets supplemen-
ted fat were examined to determine if fatty acid chain
length and degree of unsaturation alter plasma lipids or
aortic lesion development.
Dietary Fat Type
The amount of supplemental dietary fat has
ranged from 0 to 20% (w/w) [30,32,36,48,51,62,76-
78,85,90,95-97], with 10% (w/w) used most frequently
[31,33-35,37-43,45,47,50,52-56,59,63,65,66,79-84,88,92,9-
4,98,99]. Ten percent saturated fatty acids (SFA) with
supplemental cholesterol has been consistently reported
to raise plasma total cholesterol and nHDL-C concen-
trations [31,38,47,50,55,62] without having adverse
effects on hepatic function [51]. The most commonly
used sources of SFA were coconut oil [31-35,39-44,47,
50,52,54,56,59,61,63,66,80,83,84,86,88,94,99,100], fully-
hydrogenated coconut oil [32,38,48,62,78,82] and butter
[22,30,47,49,51,53,55,57,58,85,101,102]. Comparison fats
were either monounsaturated fatty acids (MUFA) or
omega-6 polyunsaturated fatty acids (n-6 PUFA). The
most commonly used source of MUFA were canola
[44,47,53] and olive [37,56,76,98] oils, and n-6 PUFA
were soybean [47,53,94], safflower [56,102] and sun-
flower [37,45,46] oils. The most commonly used source
of very long chain omega-3 PUFA (n-3 PUFA) was fish
oil [95,96,102-104].
Data Presentation
Due to the nature of the data identified it was presented
within subsections; plasma lipids and lipoproteins, and
aortic lesion. Within each subsection, the data were pre-
sented by hamster strain, background diet, dietary cho-
lesterol and dietary fat type. The figures are a visual
representation summarizing the data extracted. They are
one approach to represent the range of findings. Obser-
vations discussed in the plasma lipid and lipoprotein
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and aortic lesion subsections were made on the basis of
visual assessments rather than statistical analysis which
was precluded due to the heterogeneous nature of the
data in terms of study designs, dietary perturbations and
hamster strains.
Plasma Lipid and Lipoproteins
Hamster Strain
In response to cholesterol- and SFA-supplemented diets,
the inbred F1B [28,31-33,35,39,41-44,54-56,59,61-63,
77,80,86,94,96,98,100,105] hamster has been more con-
sistently reported to develop an atherogenic lipoprotein
profile (nHDL-C > HDL-C) than any of the three
outbred strains, CR [28,34,36,40,47-49,53,55,66,
84,88,94,99,102,106], Sasco [30,51] and Harlan
[28,85,107] hamsters (Figure 1A-C). In the outbred
strains, in contrast to that normally observed in humans,
the HDL-C concentrations were equal to or slightly
higher than nHDL-C concentrations. Noteworthy was
the wide range of plasma cholesterol concentrations
after the hamsters were fed a cholesterol- and SFA-sup-
plemented diet, regardless of strain (Figure 1A-C)
[22,24,28,30-36,38-44,47-59,61-64,66,75,77,78,80- 86,88,
89,92,94,96,98-100,105-114]
Inbred and outbred hamster strains exhibited a wide
range of plasma TG concentrations, with the F1B ham-
sters exhibiting the widest absolute range (119 to 1350
mg/dL) [28,31,33,35,38,39,41-44,52,54-56,59,62,63,77,80,
86,94,96,98,100,105] (Figure 1D). The hypertriglyceride-
mia in the inbred and outbred hamster strains fed cho-
lesterol- and SFA-supplemented diet appeared to be
inconsistent with the response in humans, which tended
to be null or increased slightly [115,116].
Age at initiation of dietary intervention did not show a
clear pattern with regard to plasma lipoprotein concen-
trations and ranged from 2 to 28 weeks. Of note, over
half of F1B hamsters started a study at 8 weeks of age.
Amount of dietary cholesterol and amount and type of
Figure 1 Plasma lipoprotein concentrations in Golden-Syrian hamsters fed cholesterol- and SFA-supplemented non-purified and semi-
purified diets. Plasma (A) HDL-C, (B) nHDL, (C) nHDL-C:HDL ratio and (D) TG concentrations in different strains of the Golden-Syrian hamster
fed cholesterol- and SFA-supplemented diets.
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dietary fat could partially explain the wide range of
plasma lipoprotein concentrations reported and will be
discussed in subsequent sections. Because the majority
of data available relate to the F1B hamster the subse-
quent discussion will be limited to that strain; however,
data for all the strains was summarized in supplemen-
tary tables and figures.
Background Diet
F1B hamsters fed non-purified diets supplemented with
cholesterol and SFA [22,31,33-36,38-44,47,48,50,52,53,
55,58,59,61,63,64,66,80,82,84-86,88,98-100,105-107,114]
resulted in lower HDL-C (Figure 2A) and higher nHDL-
C concentrations (Figure 2B) than the same strain fed a
semi-purified diet supplemented with cholesterol and
SFA [30,32,46,51,54,56,62,75,77,78,81,83,89,92,94,102,
108-110,112,113]. Of note, the resulting nHDL-C:HDL-
C ratios were higher in the majority of studies using
non-purified, but not semi-purified diets (Figure 2C).
No notable difference in response to the two back-
ground diets in plasma TG concentrations was observed
(Figure 2D) [31,33-49,52-56,59,62,63,66,76,77,80,84-86,
88,94-96,98, 100-102,107].
With respect to differences identified in plasma lipo-
protein concentrations resulting from the two back-
ground diets, potential differences in fiber and/or other
non-essential dietary components, such as phytochem-
icals, between the non-purified and semi-purified diets
could account for the differences. No data addressing
this variable was identified.
Diet Composition
Dietary Cholesterol In the absence of supplemental
dietary fat, the higher the dietary cholesterol, the higher
the resulting nHDL-C concentrations [53,73,87,117,118].
Hamsters fed a non-purified diet supplemented with 1%
(w/w) cholesterol resulted in higher nHDL-C concentra-
tions [117] compared to hamsters fed similar diets con-
taining less cholesterol [0.1-0.2% (w/w)] [53,73,87,118].
Cholesterol added to semi-purified diets ranging from
0.1-0.3% (w/w) without supplemental fat resulted in
similar nHDL-C concentrations [79,82,91,119,120].
There were no studies in hamsters fed semi-purified
diets with greater than 0.3% (w/w) cholesterol in the
absence of supplemental fat.
Compared to cholesterol-supplemented semi-purified
diets [79,82,91,119], supplementing non-purified diets
[53,87,117,118] with cholesterol, in the absence of sup-
plemental fat, was reported to result in similar nHDL-C
concentrations (Additional file 1Figure S1B). Note-
worthy, cholesterol-supplemented semi-purified diets
[79,82,91,119] without supplemental fat consistently
resulted in higher HDL-C concentrations compared to
non-purified diets [53,87,117,118] (Additional file 1Fig-
ure S1A).
Dietary Fat
SFA, MUFA and n-6 PUFA In response to cholesterol-
and SFA-, MUFA- or n-6 PUFA-supplemented diets,
HDL-C concentrations were higher, nHDL-C:HDL-C
ratio were lower, and nHDL-C and TG concentrations
were similar in F1B hamsters fed semi-purified diets
compared to non-purified diets (Figure 3A-D)
[28,44,46,56,94,98,105]. However, there were no differ-
ences in plasma lipoprotein concentrations among fat
types in hamsters fed either non-purified or semi-puri-
fied diets (Figure 3A-D).
Of note was the trend of a positive relationship
between HDL-C and TG concentrations in F1B ham-
sters fed semi-purified diets regardless of fat type
(Figure 3A&3D). This response was in contrast to
humans, who tend to exhibit an inverse relationship
between the two lipoprotein fractions [121].
Very Long Chain n-3 PUFA Notable was an anomaly in
the F1B hamster with regard to fish oil (very long chain
n-3 fatty acid) and plasma lipoprotein response. In
humans, fish oil has little effect on plasma cholesterol
concentrations [122]. Similarly, in F1B hamsters fed fish
oil-supplemented semi-purified diets without cholesterol
there was little effect on plasma cholesterol concentra-
tions (data not shown) [96,104]. However, when choles-
terol was included in the diet, the response was highly
variable and in some cases resulted in extreme eleva-
tions in nHDL-C concentrations (Figure 4A-C)
[56,96,102,104]. Similar data using non-purified diets
supplemented with fish oil were unavailable.
In hypertriglyceridemic patients, high intakes (3-
5 grams/day) of very long chain n-3 fatty acids
decreased plasma TG concentrations [123]. In contrast,
hamsters fed cholesterol- and fish oil-supplemented
semi-purified diets plasma TG concentrations increased
1- to 5-fold compared to cholesterol- and SFA- or n-6
PUFA-supplemented semi-purified diets (Figure 4D)
[95,96,103]. When data were available for other hamster




In response to cholesterol- and SFA-supplemented diets,
three studies reported that F1B [31,38,100] and CR
[22,49,55] and one unknown strain of hamster [50]
responded with an increase in lesion lipid or foam cell
formation compared to chow fed hamsters (Table 1). In
contrast, one study in F1B [55], one study in CR [47]
and one in an unknown strain [58] reported no lesion
development compared to chow (Table 1). The only
aortic lesion development data reported for Sasco
hamsters compared diets supplemented with cholesterol
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and SFA, with no comparison to chow or an unsupple-
mented diet [30,51]. No studies were identified that
reported data on the development of aortic lesions in
Harlan hamsters. The method used to characterize aor-
tic lesion development, age at initiation of dietary inter-
vention, and length of dietary intervention was different
among studies, making cross comparisons difficult to
interpret (Table 1).
Background Diet
Despite differences in the plasma lipoprotein profile, the
dearth of data precluded an assessment of whether
background diet onto which the cholesterol and SFA
was superimposed altered aortic lesion development.
Diet Composition
Dietary Cholesterol Only two studies were identified
that reported the effect of dietary cholesterol on aortic
lesion development. Dietary cholesterol at 0.12 and 0.2%
(w/w) added to a semi-purified diet in the absence of
supplemental fat increased stained aortic lesion area
compared to a non-supplemented semi-purified diet
[46,91]. Similar data using non-purified diets were
unavailable.
As noted with the plasma lipoprotein response, a wide
range in degree of aortic lesion development was noted
after the hamsters were fed a cholesterol- and SFA-
supplemented diet, regardless of strain (Table 1)
[31,38,47,49,50,55,58].
Dietary Fat Five studies were identified that contained
data on aortic lesion development in F1B hamsters in
response to different types of dietary fat. Regardless of
background diet or supplemental cholesterol, no differ-
ences were observed in response to dietary fat type
[39,54,56,105] (Table 2). The multiple methods used to
assess aortic lesion formation did not appear to impact
the outcomes reported. Considering the data from all
the hamster strains simultaneously did not alter this
conclusion (Additional file 3: Table S1). However, 2 out
of 8 studies reported a larger fatty streak area in choles-
terol- and SFA-supplemented non-purified diets com-
pared to cholesterol- and MUFA-supplemented non-
purified diets [36,64]. When comparing stained fatty
streak area between cholesterol- and MUFA- or n-6
PUFA-supplemented hamsters, the latter group exhib-
ited more lesion [45] and aortic CE accumulation [37].
Conclusion
Early work suggested that hamsters fed diets supple-
mented with cholesterol and SFA were a useful animal
model to study diet induced atherosclerosis. Hamsters
appeared to respond to a cholesterol- and SFA-supple-
mented diet by increasing nHDL-C, ultimately leading
to enhanced deposition of cholesterol in the aorta and
increased atherosclerotic lesion development. More
recent data were less consistent on the usefulness of the
model.
Table 2 Aortic lesion development in F1B Golden-Syrian hamsters fed supplemented non-purified and
semi-purified diets
Ref Strain % Fat (w/w) % CH (w/w) Diet 1 Diet 2 Outcome Outcome Variable
[39] F1B 102 0.1 CO CLA ↔ CE (ug)/aorta (mg)
[39] F1B 102 0.1 CO LA ↔ CE (ug)/aorta (mg)
[39] F1B 102 0.1 CO CLA + LA ↔ CE (ug)/aorta (mg)
[105] F1B 102 0.15 CO Safflower Oil ↔ CE (ug)/aorta (mg)
[54] F1B 103 0.1 Palm Oil/CO Macademia Oil ↔ CE (ug)/aorta (mg)
[54] F1B 103 0.1 Palm Oil/CO Canola Oil ↔ CE (ug)/aorta (mg)
[54] F1B 103 0.1 Palm Oil/CO Safflower Oil ↔ CE (ug)/aorta (mg)
[54] F1B 103 0.1 Macademia Oil Canola Oil ↔ CE (ug)/aorta (mg)
[54] F1B 103 0.1 Macademia Oil Safflower Oil ↔ CE (ug)/aorta (mg)
[54] F1B 103 0.1 Canola Oil Safflower Oil ↔ CE (ug)/aorta (mg)
[56] F1B 103 0.1 CO Olive Oil ↔ CE (ug)/aorta (mg)
[56] F1B 103 0.1 CO Safflower Oil ↔ CE (ug)/aorta (mg)
[56] F1B 103 0.1 Olive Oil Safflower Oil ↔ CE (ug)/aorta (mg)
[105] F1B 103 0.15 CO Safflower Oil ↔ CE (ug)/aorta (mg)
F1B1 103 0.1 CO Fish Oil ↔ CE (ug)/aorta (mg)
F1B1 103 0.1 Olive Oil Fish Oil ↔ CE (ug)/aorta (mg)
F1B1 103 0.1 Safflower Oil Fish Oil ↔ CE (ug)/aorta (mg)
CH: cholesterol; CO: coconut oil; CLA: conjugated linoleic acid; LA: linoleic acid; CE: cholesteryl ester. 1Dillard (unpublished data), 2Non-purified diet,
3Semi-Purified diet
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Figure 2 Plasma lipoprotein concentrations in F1B hamsters fed cholesterol- and SFA-supplemented non-purified or semi-purified
diets. Plasma (A) HDL-C, (B) nHDL, (C) nHDL-C:HDL ratio and (D) TG concentrations in F1B hamsters fed cholesterol- and SFA-supplemented
non-purified or semi-purified diets.
Figure 3 Plasma lipoprotein concentrations in F1B hamsters fed cholesterol- and SFA-, MUFA, or n-6 PUFA-supplemented diets. Plasma
(A) HDL-C, (B) nHDL, (C) nHDL-C:HDL ratio and (D) TG concentrations in F1B hamsters fed cholesterol- and SFA-, MUFA- or n-6 PUFA-
supplemented non-purified or semi-purified diets.
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The data showed a relatively consistent response of
the F1B hamsters fed cholesterol- and SFA-supple-
mented diets to develop an atherogenic lipoprotein
profile (nHDL-C > HDL-C). For those studies in
which aortic lesion data were also available, an athero-
genic lipoprotein profile did not consistently result in
lesion development. No hamster strain consistently
developed aortic lesions regardless of atherogenic lipo-
protein profile. Data relating other hamster strains to
diet induced changes in lipoprotein profile or lesion
development were too limited and inconsistent to
draw conclusions.
On the basis of limited data, it appears that non-puri-
fied diets containing 0.1% to 0.2% (w/w) dietary choles-
terol were most commonly associated with eliciting an
atherogenic lipoprotein profile without compromising
hepatic function. There was insufficient data to deter-
mine the effect of dietary cholesterol alone on aortic
lesion development. Potential hamster strain differences
in response to dietary cholesterol could not be
addressed in this review due to insufficient data.
In summary, F1B hamsters fed non-purified diets
supplemented with cholesterol and SFA led to a
more atherogenic lipoprotein profile compared to all
other hamster strains as well as F1B hamsters fed
similarly supplemented semi-purified diets. This
would suggest that F1B hamsters fed a cholesterol-
and SFA-supplemented non-purified diet would be a
good model in which to compare and contrast diet-
induced changes in plasma lipoprotein concentra-
tions. However, fat type including SFA, MUFA and
n-6 PUFA had little effect on plasma lipoprotein
concentrations. Cholesterol- and fish oil-supplemen-
ted semi-purified diets produced highly variable
plasma lipoprotein responses and results antithetical
to that observed in humans.
Figure 4 Plasma lipoprotein concentrations in F1B hamsters fed cholesterol- and SFA-, n-6PUFA- or fish oil-supplemented semi-
purified diets. Plasma (A) HDL-C, (B) nHDL, (C) nHDL-C:HDL ratio and (D) TG concentrations in F1B hamsters fed cholesterol- and SFA-, n-6
PUFA- or fish oil-supplemented non-purified or semi-purified diets.
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Aortic lesion development in response to dietary fat
type was inconsistent and inconclusive because no ham-
ster strain repeatedly developed aortic lesions regardless
of background diet, amount of dietary cholesterol, or
amount and type of dietary fat.
On the basis of available data it does not appear at
this time that the hamster is a useful model to deter-
mine the mechanisms underlying the development of
diet-induced atherosclerosis. If this model were to be
pursued it will be important to develop a standardized
atherogenic diet and length of dietary intervention tai-
lored to a specific hamster species, explore potential
issues related to sex differences, and come to consensus
for the analytical approaches most appropriate to assess
the outcome measures of interest.
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